To determine the seroprevalence of HBsAg in the prevalence of HBsAg positivity among male and female blood donors. Materials and Methods: A retrospective study was conducted in blood bank. Voluntary and replacement blood donors including male and female donors over a period of two years six month to assess the prevalence of hepatitis B virus infection. ELISA method and alternatively Hepacard kit were used for screening the donors. Results: A retrospective study was carried on 7,018 blood donors out of which males were 5,936 and 1,082 were females. The prevalence of HBsAg sero positivity in 2011 July to December in male donors were 2.8%; in female donors 0.0%; 2012 January to December in male donors were 2.9% and female donors were 0.3%; 2013 January to December in male donors were 1.8% and Female donors were 0.0%. Overall prevalence was estimated to be 7.8%. Conclusion: Hepatitis B infection remains a signifi cant public health problem in India and its seroprevalence was more as compared to other transfusion transmitted infections, especially in younger age group. The increasing prevalence of HBsAg can be reduced by more sensitive screening assays.
INTRODUCTION
Hepatitis B infection has become one of the major global health problems. Hepatitis B causes an estimated 1-2 million deaths per year worldwide. 1, 2 It is estimated that there are 300 million carriers of Hepatitis B virus in the world, countries are classifi ed on the basis of endemicity of Hepatitis B virus infection. Highest carriers in equatorial Africa 8% or more and in South East Asia, China, parts of South America intermediate 2-7% in Eastern Europe, middle East, South Asia carrier rate low <2% in developed countries as North America and Australia incidence countries. 1 The prevalence of chronic hepatitis B infection in India ranges from 2-10% as shown by different studies. 2 The screening of donors help in determining safe transfusion of the blood and its products, also gives an idea about seroprevalence of Hepatitis B infection in the community.
The prevalence of hepatitis B virus was more in coastal parts of Karnataka as compare to other areas. The results of these prevalence studies should helps in improving public health and to prevent spreading of the disease in the local population. According to the WHO classifi cation, the coastal part of Karnataka qualifi es as a low prevalence area of hepatitis B infection (less than 2%). The data providing a picture of hepatitis B infection burden in India has come from HBsAg seroprevalence studies along with advanced technology such as nucleic acid testing (NAT) for donor screening, other factors such as public awareness, educational and motivational programs, and mass immunization programs help in decreasing the hepatitis B infection. 2 The Hepatitis B infection is one of the leading cause of morbidity and mortality not only because of the acute illness but also due to chronic hepatitis, cirrhosis and hepatocellular carcinoma. Currently, hepatitis B infection is transmitted through -infected mother to child at birth, contact with infected person, sexual contact with infected person and parenteral route through blood and body fl uids. 3 HBsAg in the serum is the earliest marker of active HBV infection in both acute and chronic infection being detectable even before elimination of transaminases and onset of clinical illness. According to some studies to reduce risk of the transfusion transmitted infections includes; improving and proper donor selection, testing the donated blood for specifi c antibodies against hepatitis B virus by using ELISA method. 4 The safety of the blood and its components depends on a proper donor selection by sensitive screening tests to exclude the transfusion transmitted infectious agents, despite screening for HBsAg by ELISA for over 20 years, transfusion associated HBV continues to be one of the major problem in India among patients who receive multiple transfusions. The prevalence of the post transfusion Hepatitis B infection in India ranges from 1 to 5%. 5 Hence here in this study, our objective is to determine the seroprevalence of HBsAg in the prevalence of HBsAg positivity among male and female blood donors.
MATERIAL AND METHODS
This retrospective study was conducted over a period of two years six months from July 2011 to December 2013 at Blood Bank of BLDE University Shri B M Patil Medical College, Hospital and Research Centre, Bijapur, Karnataka, India.
A total 7,018 voluntary and replacement blood donors were selected. This study was approved by the ethical committee of the institution. We included in this study volunteers of male and female from various blood donation camps of urban and rural population and also replacement donors of Bijapur District, Karnataka.
All donors were carefully selected for blood donation by trained personnel after a complete physical examination, vital parameters and satisfactorily answering the donor's questionnaire.
Assess HBsAg by using ELISA method (Tulip group and Erba Lisa 96 tests kit) (sensitivity 100%) (If OD exceeds 2.5 or 3 or more and negative control value is <0.1) and alternatively Hepacard spot kit (Diagnostic enterprises S-MB/09/46) were used for screening the donors.
Inclusion criteria
Donors who fulfi ll all donation criteria recommended by FDA.
Exclusion criteria
Donors who do not fulfi ll all donation criteria recommended by FDA.
RESULT
Out of the total 7,018 blood donors 5,936 (84.6%) were males and 1,082 (15.41%) were females, shown in (Table 1) . We observed that seroprevalence of HBV was higher in male donors i.e. 138 (7.7%) than in female donors i.e. 01 (0.3%), ( Table 2) . Out of total blood donors 139 donors were positive for HBsAg in that 112 donors were ≤40 years of age and 27 donors were >40 years of age (Table 3 ). Figure 1 shows the distribution of male and female blood donors at three different time points. It is evident here that proportion of males is more than three times the females in 2011 while this rose to more than four times in 2012 and 2013. 112 donors were ≤ 40 years of age and 27 donors were > 40 years of age (Table 3) . In our study we observed that seroprevalence of Hepatitis B infection is more prevalent in younger age group and predominantly in male donors.
DISCUSSION
Hepatitis B is one of the most common transfusion transmissible infections. The prevalence of this infection varies across the different geographical regions. Noting the trend of seroprevalence of hepatitis B is useful to assist the preventive strategies. The aim of this study was to determine the trend of seroprevalence of hepatitis B in Bijapur District, Karnataka over a period of two years six months.
Glynn SA et al in their study stated that Hepatitis B infection is one of the major health problem which affects two Billions of people throughout worldwide and 350 million people suffer from the chronic HBV infection. 4 In India the prevalence of the Hepatitis B infection is 4% in the general population, which means that 40 million people are infected with hepatitis B infection. 5 Schmidt M et al in their study found that, prevalence of the HBV infection in the voluntary blood donors is 1-3% and 0-12% in the commercial donors.6 In our study, among the 7,018 blood donors screened, the overall seroprevalence of HBsAg was observed to be 1.32%.
Chandrasekaran S & Karki S et al in their study found that seroprevalence of hepatitis B infection was signifi cantly high in male donors as compared to female donors. As in our study also seroprevalence of hepatitis B infection among male donors was signifi cantly high there was no signifi cant difference in the prevalence rates of HBsAg seropositivity among male and female donors in our study because male donors are predominant compared to female donors. 7, 8 Rodenas et al reported in their study higher prevalence of HBsAg positivity in donors older than 38 years. 9 In our study we found that the majority of seropositive HBsAg donors were younger than 40 years.
Many studies reported that seroprevalence of hepatitis B infection higher in males than in females. Singh K et al screened, 30,428 blood donors the overall seroprevalence of HBsAg was observed to be 0.62% out of the total 30,428 blood donors, 28,046 (92.17%) were males and 2,382 (7.83%) were females with male to female ratio of 11.77:1. A higher seroprevalence rate was observed among male donors than in female blood donors (0.65% versus 0.25% respectively). 2 Chowdhury A et al in their study they compared the demographic characteristics of the participants with the among general population of Birbhum district as well as West Bengal the participation rate among female subjects (83.88%) was lower than that of male subjects (90.15%). 10 In our study we screened for Hepatitis B infection of total of 7,018 donors including both male and female donors of which we reported that 139 donors were seropositive for HBs Ag.
Lavanya V et al screened a total of 200 blood donors during their study among them a vast majority was males (184: 92%), male to female ratio of 11.5:1. Out of the 200 samples studied, 7 of them were found to be positive for HBsAg. The prevalence rate of HBsAg was (7/200) 3.5%. All the positive cases were male and no female donors were found to be positive for HBsAg. Age wise prevalence was found to be more in 31 to 35 years group. 11 In this study age wise distribution we found high seroprevalence of hepatitis B infection in younger age group between 19 to 40 years group.
Karki S et al in their study reported that the seroprevalence of hepatitis B infection high in male donors as compared to female donors, but in their study the majority of blood donors were males. The statistical analysis (chi-square test) shows signifi cant difference in the seroprevalence of hepatitis B Infection (p value -0.024). 8 In our study male donors were predominant total 5,936 compared to female donors 1,082 we also observed a higher seroprevalence rate among male donors than in female blood donors. Nilima In our study we observed that seroprevalence hepatitis B infection was more prevalent compared to other transfusion transmitted infection, especially among younger age group.
CONCLUSION
Seroprevalence hepatitis B infection was more prevalent compared to other transfusion transmitted infection, especially among younger age group and will continue to do so as long as commercial blood banks remain operational and until appropriate nationwide vaccination programmes and other control measures are established. The increasing prevalence of HBsAg can be reduced by more sensitive screening assays and proper donor selection.
